Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Dynamic Expedition of Leading Mutations in SARS-CoV-2 Spike Glycoproteins

Open access
Hasan, Muhammad, He, Zhouyi, Jia, Mengqi, Leung, Alvin C. F., Natarajan, Kathiresan, Xu, Wentao, Yap, Shanqi, Zhou, Feng, Chen, Shihong, Su, Hailei, Zhu, Kaicheng, Su, Haibin · 2021 · Computational and Structural Biotechnology Journal

Preprint — published as 10.1016/j.csbj.2024.05.037 · Paper page

Abstract

Throughout the coronavirus disease 2019 (COVID-19) pandemic, the continuous genomic evolution of its etiological agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has generated many new variants with enhanced transmissibility and immune escape capabilities. Being an essential mediator of infections and a key target of antibodies, mutations of its spike glycoprotein play a vital role in modulating its evolutionary trajectory. Here, we present a time-resolved statistical method, Dynamic Expedition of Leading Mutations (deLemus), to analyze the evolutionary dynamics of the SARS-CoV-2 spike. Together with analysis of its single amino acid polymorphism (SAP), we propose the use of L -index in quantifying the mutation strength of each amino acid site, such that the evolutionary mutation pattern of the spike glycoprotein can be unravelled.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.12.29.474427

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Confirmed leading mutation sites (red spheres) in different domains of the SARS-CoV-2 spike glycoprotein. (a) A SARS-CoV-2 spike glycoprotein monomer (generated by AlphaFold2, Colab version, using the reference sequence EPI_ISL_402124) encompassing the four major functional domains: NTD, RBD, CTDs (CTD1&2), and S2. (b) Mutation sites outlined in the NTD (green), most of which are clustered in the outer regions. (c) Mutation sites outlined in the RBD (yellow), nearly all the captured mutations are located in the receptor-binding motif. (d) Mutation sites outlined in the CTDs (pink). (e) Mutation sites outlined in S2 (cyan).
Fig. 1 Confirmed leading mutation sites (red spheres) in different domains of the SARS-CoV-2 spike glycoprotein. (a) A SARS-CoV-2 spike glycoprotein monomer (generated by AlphaFold2, Colab version, using the reference sequence EPI_ISL_402124) encompassing the four major functional domains: NTD, RBD, CTDs (CTD1&2), and S2. (b) Mutation sites outlined in the NTD (green), most of which are clustered in the outer regions. (c) Mutation sites outlined in the RBD (yellow), nearly all the captured mutations are located in the receptor-binding motif. (d) Mutation sites outlined in the CTDs (pink). (e) Mutation sites outlined in S2 (cyan).CC BY-NC-ND · PubMed Central
Fig. 2 Evolutionary trajectory of the N-terminal domain (NTD). The x-axis denotes mutable sites within the domain. The y-axis represents time in months, spanning from January 2020 to December 2021. The Variants of Concern (VOCs) are represented by the following colors: red (α, B.1.1.7), light blue (β, B.1.351), purple (γ, P.1), green (δ, B.1.617.2), and blue (o, BA.1, BA.2). The Variants of Interest (VOIs) are depicted in pink: ϵ (B.1.427, B.1.429), ι (B.1.526), η (B.1.525), κ (B.1.617.1), λ (C.37), and μ (B.1.621). Reported mutations from VOCs and VOIs are depicted in gray. The orange circles represent the mutation outlined by the L-index. The vertical dashed lines indicate the confirmed mutations identified by the L-index within the reported VOCs/VOIs. Each circle is labeled with a letter representing the corresponding mutated amino acid, such as Δ (Deletion), A (Alanine), C (Cysteine), D (Aspartic Acid), etc. Unmarked circles correspond to the same amino acids as the labeled circles below.
Fig. 2 Evolutionary trajectory of the N-terminal domain (NTD). The x-axis denotes mutable sites within the domain. The y-axis represents time in months, spanning from January 2020 to December 2021. The Variants of Concern (VOCs) are represented by the following colors: red (α, B.1.1.7), light blue (β, B.1.351), purple (γ, P.1), green (δ, B.1.617.2), and blue (o, BA.1, BA.2). The Variants of Interest (VOIs) are depicted in pink: ϵ (B.1.427, B.1.429), ι (B.1.526), η (B.1.525), κ (B.1.617.1), λ (C.37), and μ (B.1.621). Reported mutations from VOCs and VOIs are depicted in gray. The orange circles represent the mutation outlined by the L-index. The vertical dashed lines indicate the confirmed mutations identified by the L-index within the reported VOCs/VOIs. Each circle is labeled with a letter representing the corresponding mutated amino acid, such as Δ (Deletion), A (Alanine), C (Cysteine), D (Aspartic Acid), etc. Unmarked circles correspond to the same amino acids as the labeled circles below.CC BY-NC-ND · PubMed Central
Fig. 3 Evolutionary trajectory of the receptor-binding domain (RBD). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 3 Evolutionary trajectory of the receptor-binding domain (RBD). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central
Fig. 4 Data analysis on deep mutational scanning from published work [70]. (a) 3D structure illustration of leading mutations outlined in RBD (red). (b) RBD-ACE2 binding affinity distribution with different reference virus variants. (c) Escape score of leading mutation sites.
Fig. 4 Data analysis on deep mutational scanning from published work [70]. (a) 3D structure illustration of leading mutations outlined in RBD (red). (b) RBD-ACE2 binding affinity distribution with different reference virus variants. (c) Escape score of leading mutation sites.CC BY-NC-ND · PubMed Central
Fig. 5 Evolutionary trajectory of the C-terminal domains (CTD1 and CTD2). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 5 Evolutionary trajectory of the C-terminal domains (CTD1 and CTD2). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central
Fig. 6 Evolutionary trajectory of the S2 subunit. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 6 Evolutionary trajectory of the S2 subunit. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central
Fig. 7 Evolutionary trajectory of the BA.2.86 and JN.1. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 7 Evolutionary trajectory of the BA.2.86 and JN.1. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 99

  1. 10.1038/s41586-020-2012-7 · DOI · Paper page
  2. 10.3390/v2081803 · DOI · Paper page
  3. 10.1073/pnas.0508200103 · DOI · Paper page
  4. 10.4161/rna.8.2.15013 · DOI · Paper page
  5. Abdelrahman, Z. , Li, M. & Wang, X. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front. Immunol. 11 (2020). · DOI · Paper page
  6. 2021, Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme, Science, 373, 1142, 10.1126/science.abi9310 · DOI
  7. 10.1073/pnas.2106379119 · DOI · Paper page
  8. 10.1126/science.abf6950 · DOI · Paper page
  9. 10.1126/sciadv.abb9153 · DOI · Paper page
  10. 2022, Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape, Nature, 609, 994, 10.1038/s41586-022-05189-9 · DOI
  11. 10.1038/nrmicro2614 · DOI · Paper page
  12. 2020, A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology, Nat. Microbiol, 5, 1403, 10.1038/s41564-020-0770-5 · DOI · Paper page
  13. Carabelli, A. M. , Peacock, T. P. , Thorne, L. G. , et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol. (2023). · DOI · Paper page
  14. 10.1038/S41579-021-00573-0 · DOI · Paper page
  15. 10.1126/science.abg4493 · DOI
  16. 10.1038/s41580-021-00418-x · DOI · Paper page
  17. 10.1126/science.abb2762 · DOI · Paper page
  18. 2020, Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion, Nature, 588, 327, 10.1038/s41586-020-2772-0 · DOI · Paper page
  19. 10.1016/j.molcel.2020.04.022 · DOI · Paper page
  20. 10.1126/science.abd0827 · DOI · Paper page
  21. 2021, Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells, Cell Rep. Med, 2, 100354, 10.1016/j.xcrm.2021.100354 · DOI · Paper page
  22. 10.1038/s41590-021-01122-w · DOI · Paper page
  23. 10.1038/s41401-020-0485-4 · DOI · Paper page
  24. Duan, L. , Zheng, Q. , Zhang, H. , et al. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens. Front. Immunol. 11 (2020). · DOI · Paper page
  25. 2021, Viral targets for vaccines against COVID-19, Nat. Rev. Immunol, 21, 73, 10.1038/s41577-020-00480-0 · DOI · Paper page
  26. 2021, Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2, Angew. Chem. Int, 60, 9789, 10.1002/anie.202008835 · DOI
  27. 2021, Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies, Nat. Med, 27, 717, 10.1038/s41591-021-01294-w · DOI · Paper page
  28. 2017, GISAID: Global initiative on sharing all influenza data – from vision to reality, Eurosurveillance, 22, 30494
  29. 10.1038/s41586-020-2008-3 · DOI · Paper page
  30. 10.1093/nar/gkq313 · DOI · Paper page
  31. Golub, G. H. & Van Loan, C. F. Matrix Computations 4th ed., 780 (The Johns Hopkins University Press, Maryland, 2013).
  32. 10.1126/science.abb2507 · DOI · Paper page
  33. 2021, Neutralizing and protective human monoclonal anti-bodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein, Cell, 184, 2316, 10.1016/j.cell.2021.03.029 · DOI · Paper page
  34. 2022, Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins, Immunity, 55, 998, 10.1016/j.immuni.2022.04.003 · DOI
  35. 2021, Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains, mBio, 12, e01590
  36. 10.1073/pnas.2100943118 · DOI
  37. Alisoltani, A. , Jaroszewski, L. , Iyer, M. , et al. Increased Frequency of Indels in Hypervariable Regions of SARS-CoV-2 Proteins—A Possible Signature of Adaptive Selection. Front. Genet. 13 (2022). · DOI
  38. 2022, Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution, Microbiol. Spectr, 10, e02191
  39. 2021, Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7, Cell Rep, 35, 109292, 10.1016/j.celrep.2021.109292 · DOI · Paper page
  40. 10.1126/science.abc6952 · DOI · Paper page
  41. 2021, N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2, Cell, 184, 2332, 10.1016/j.cell.2021.03.028 · DOI · Paper page
  42. 10.1038/S41591-021-01285-X · DOI · Paper page
  43. 2021, Antibody evasion by the P.1 strain of SARS-CoV-2, Cell, 184, 2939, 10.1016/j.cell.2021.03.055 · DOI · Paper page
  44. 10.1126/SCIENCE.ABJ9932 · DOI · Paper page
  45. 2022, Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants, Computat. Struct. Biotechnol. J, 20, 4501, 10.1016/j.csbj.2022.08.010 · DOI
  46. 2022, The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance, Cell Rep, 38, 110218, 10.1016/j.celrep.2021.110218 · DOI · Paper page
  47. 10.1016/S0140-6736(21)02758-6/ATTACHMENT/FB9D1AF8-6927-48BD-B7B7-A5055C3743D5/MMC1.PDF · doi:10.1016/s0140-6736(21)02758-6/attachment/fb9d1af8-6927-48bd-b7b7-a5055c3743d5/mmc1.pdf
  48. 2022, Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa, Nature, 603, 679, 10.1038/s41586-022-04411-y · DOI · Paper page
  49. 10.1038/s41586-021-04388-0 · DOI · Paper page
  50. 2021, A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants, mBio, 12, e02473
  51. 2020, Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell. Mol. Immunol, 17, 613, 10.1038/s41423-020-0400-4 · DOI · Paper page
  52. 10.1038/s41586-020-2180-5 · DOI · Paper page
  53. 10.1126/sciimmunol.abc8413 · DOI · Paper page
  54. 10.1016/J.CELL.2020.09.037 · DOI · Paper page
  55. Tao, K. , Tzou, P. L. , Nouhin, J. , et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 0123456789 (2021). · DOI · Paper page
  56. 2021, mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants, Nature, 592, 616, 10.1038/s41586-021-03324-6 · DOI · Paper page
  57. Weisblum, Y. , Schmidt, F. , Zhang, F. , et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 9 (2020). · DOI · Paper page
  58. 10.1016/J.CHOM.2021.02.003 · DOI · Paper page
  59. 10.1126/science.abd0831 · DOI · Paper page
  60. 10.1126/science.abf9302 · DOI · Paper page
  61. 10.1038/s41467-022-28324-6 · DOI
  62. Mannar, D. , Saville, J. W. , Zhu, X. , et al. Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding. Cell Rep., 110156 (2021). · doi:10.1101/2021.08.25.457711
  63. 10.1101/2021.05.26.445838 · DOI · Paper page
  64. 2020, The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity, Cell, 182, 1284, 10.1016/j.cell.2020.07.012 · DOI · Paper page
  65. 10.1016/J.CHOM.2021.01.014 · DOI · Paper page
  66. 10.1016/j.jmb.2020.07.009 · DOI · Paper page
  67. 2021, SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity, Cell Host Microbe, 29, 1124, 10.1016/j.chom.2021.06.006 · DOI · Paper page
  68. 2022, Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies, Nat. Commun, 13, 871, 10.1038/s41467-022-28528-w · DOI · Paper page
  69. 10.1039/D1CP04005G · DOI
  70. 2022, BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection, Nature, 608, 593, 10.1038/s41586-022-04980-y · DOI · Paper page
  71. 10.1016/j.jmb.2021.167051 · DOI
  72. 10.1126/science.abi6226 · DOI · Paper page
  73. 2020, Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein, Nat. Commun, 11, 3618, 10.1038/s41467-020-17371-6 · DOI · Paper page
  74. 2020, Controlling the SARS-CoV-2 spike glycoprotein conformation, Nat. Struct. Mol. Biol, 27, 925, 10.1038/s41594-020-0479-4 · DOI · Paper page
  75. 10.1016/j.celrep.2020.108630 · DOI · Paper page
  76. 2021, Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function, Nat. Struct. Mol. Biol, 28, 731, 10.1038/s41594-021-00652-z · DOI
  77. 10.1073/pnas.2111199119 · DOI
  78. 10.1073/pnas.0809524106 · DOI · Paper page
  79. 10.1016/j.jmb.2021.167280 · DOI · Paper page
  80. 2020, Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site, iScience, 23, 101212, 10.1016/j.isci.2020.101212 · DOI · Paper page
  81. 10.1016/j.cell.2020.06.043 · DOI · Paper page
  82. Gobeil, S. M.-C. , Janowska, K. , McDowell, S. , et al. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Rep. 34 (2021). · DOI · Paper page
  83. 10.1038/s41467-021-21118-2 · DOI · Paper page
  84. 2021, SARS-CoV-2 spike D614G change enhances replication and transmission, Nature, 592, 122, 10.1038/s41586-021-03361-1 · DOI · Paper page
  85. 10.1038/nsb941 · DOI · Paper page
  86. 10.1021/acs.jpclett.0c01698 · DOI
  87. 2022, Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike, iScience, 25, 103589, 10.1016/j.isci.2021.103589 · DOI · Paper page
  88. 10.1128/mBio.02510-21 · DOI
  89. 10.1038/s41586-021-04266-9 · DOI · Paper page
  90. Liu, Y. , Liu, J. , Johnson, B. A. , et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Cell Rep. 39 (2022). · DOI · Paper page
  91. 10.1016/j.celrep.2022.110729 · DOI
  92. 10.1016/j.tig.2010.05.003 · DOI · Paper page
  93. 2018, Complexities of Viral Mutation Rates, J. Virol, 92, e01031
  94. 10.1016/0092-8674(78)90223-4 · DOI · Paper page
  95. 10.1146/annurev.mi.41.100187.002205 · DOI · Paper page
  96. 10.1038/42701 · DOI · Paper page
  97. 10.1073/pnas.1705887114 · DOI
  98. 10.1038/nrg.2016.58 · DOI · Paper page
  99. 10.1016/j.chom.2021.03.005 · DOI · Paper page

Metadata

Authors
Hasan, M., He, Z., Jia, M., Leung, A. C. F., Natarajan, K., Xu, W., Yap, S., Zhou, F., Chen, S., Su, H., Zhu, K., & Su, H.
Affiliations
  • Hong Kong University of Science and Technology (HK)
  • Rajiv Gandhi Centre for Biotechnology (IN)
Corresponding author
  • Su, Hailei
  • Zhu, Kaicheng
  • Su, Haibin
Venue
Computational and Structural Biotechnology Journal
Publisher
openRxiv
Published
2021-12-29
Volume
23
Pages
2407-2417
ISSN
2001-0370 (ISSN-L)
OpenAlex
W4398765285
Cited by
3
References
1
Citations by year
2026: 2 · 2025: 1
FWCI
1.04
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Computational and Structural Biotechnology Journal (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
Funders
Hong Kong University of Science and Technology (R9418)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
SARS-CoV-2, spike protein, viral evolution, L-index, viral variants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dynamic Expedition of Leading Mutations in SARS-CoV-2 Spike Glycoproteins. https://app.cochat.ai/papers/10.1101/2021.12.29.474427
The paper
Hasan, M., He, Z., Jia, M., Leung, A. C. F., Natarajan, K., Xu, W., Yap, S., Zhou, F., Chen, S., Su, H., Zhu, K., & Su, H. (2021). Dynamic Expedition of Leading Mutations in SARS-CoV-2 Spike Glycoproteins. Computational and Structural Biotechnology Journal. https://doi.org/10.1101/2021.12.29.474427

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.